Sheldon M. Feldman
Expertise in
10
conditions

Dr. Sheldon M. Feldman

General Surgery
Montefiore Einstein
Montefiore At 1250 Waters Place
1250 Waters Place, 
Bronx, NY 

Expertise in
10
conditions
Montefiore Einstein
Montefiore At 1250 Waters Place
1250 Waters Place, 
Bronx, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication.

Dr. Feldman is highly rated in 10 conditions, according to our data. His top areas of expertise are Intraductal Papilloma, Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
New York University School Of Medicine
Residency
NYU Medical Center
Specialties
General Surgery
Licenses
Surgery in NY
Fellowships
Newark Beth Israel Medical Center
Hospital Affiliations
Montefiore Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Archcare
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Hamaspik
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Montefiore at 1250 Waters Place
1250 Waters Place, Bronx, NY 10461
Call: 844-273-2786
Other Locations
Brook Avenue at 951 Breast Surgery
951 Brook Avenue, Bronx, NY 10451
Call: 718-862-8840

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
A Prospective Multi-center Clinical Study Evaluating the Use of PD G 506 A and the Eagle V1.2 Imaging System for the Visualization of Carcinoma During Breast Conserving Surgery
Enrollment Status: Terminated
Publish Date: September 03, 2025
Intervention Type: Drug, Device
Study Drug: Aminolevulinic Acid Hydrochloride
Study Phase: Phase 3
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
Cryoablation of Low Risk Breast Cancer Less Than 1.5 cm: An Evaluation of Local Recurrence (Ice3 Trial)
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)
Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Other, Procedure
Study Phase: Not Applicable
TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions
TBCRC 042 - A Randomized Phase II Window-of-Opportunity Trial of Ruxolitinib in Patients With High Risk and Premalignant Breast Conditions
Enrollment Status: Active_not_recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Drug: Ruxolitinib
Study Phase: Phase 2
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
An Open Label, Phase 2 Pharmacokinetic Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy or Lumpectomy
Enrollment Status: Terminated
Publish Date: April 03, 2024
Intervention Type: Drug
Study Phase: Phase 2
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Enrollment Status: Terminated
Publish Date: November 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer
Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer
Enrollment Status: Terminated
Publish Date: November 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application
American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application
Enrollment Status: Completed
Publish Date: August 04, 2023
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001
MarginProbe® System U.S. Post-Approval Study Protocol CP-07-001
Enrollment Status: Unknown
Publish Date: August 18, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Device, Drug
Study Drug: AVB-620
Study Phase: Phase 2
Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer
Identification of Sentinel Lymph Nodes by Ultrasound Utilizing Iron Tracer Injection and Preoperative Biopsy in Women With Breast Cancer
Enrollment Status: Withdrawn
Publish Date: March 26, 2019
Intervention Type: Drug, Procedure
Study Phase: Early Phase 1
View 12 Less Clinical Trials

87 Total Publications

Intra-Operative Radiotherapy with Photons - Update of a Single Institution Registry Trial.
Intra-Operative Radiotherapy with Photons - Update of a Single Institution Registry Trial.
Journal: Clinical breast cancer
Published: June 30, 2025
View All 87 Publications
Similar Doctors
Expertise in
41
conditions
Dr. William R. Jarnagin
General Surgery
Expertise in
41
conditions
Dr. William R. Jarnagin
General Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (9.0 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Jarnagin is a General Surgeon in New York, New York. Dr. Jarnagin is highly rated in 41 conditions, according to our data. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gallbladder Cancer, Hepatectomy, and Pancreatectomy.

Christopher L. Wolfgang
Expertise in
24
conditions
Dr. Christopher L. Wolfgang
General Surgery | Surgical Oncology
Expertise in
24
conditions
Dr. Christopher L. Wolfgang
General Surgery | Surgical Oncology

New York University

577 1st Ave., 2nd Floor, 
New York, NY 
 (10.7 miles away)
212-263-2630
Languages Spoken:
English
See accepted insurances
Offers Telehealth

As a hepatobiliary and pancreatic surgeon, my expertise is in the surgical care of people who have cancer or benign disease of the pancreas, gallbladder, liver, and ampulla. However, my main area of expertise is pancreatic cancer.I chose to specialize in pancreatic cancer for a variety of reasons. It is a complex and aggressive disease that requires surgical and medical management based on innovative research. In addition, providing surgical treatment for pancreatic cancer demands great technical skills, and effective treatment requires a team of experts with access to the most sophisticated technology available.At Perlmutter Cancer Center, we perform more than 100 Whipple procedures—a complex surgery for cancer in the head of the pancreas—each year with outstanding outcomes. The mortality rate of Whipple procedures at our center is among the lowest in the world. I have performed more than 1,200 of these procedures.Our team has expertise in robotic surgery of the pancreas and liver, as well as in the removal of pancreatic tumors that involve major vessels, which is also known as locally advanced pancreatic cancer. We use transplants to manage certain types of liver tumors and offer precision treatment for all stages of pancreatic cancer. Our patients have access to the most advanced clinical trials.I feel privileged to share in the lives of people who have received a diagnosis of pancreatic cancer and shepherd them through treatment. One of the most rewarding parts of. Dr. Wolfgang is highly rated in 24 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Ashok R. Shaha
Expertise in
10
conditions
Dr. Ashok R. Shaha
General Surgery
Expertise in
10
conditions
Dr. Ashok R. Shaha
General Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (9.0 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashok Shaha is a General Surgeon in New York, New York. Dr. Shaha is highly rated in 10 conditions, according to our data. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

VIEW MORE General Surgeons

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Feldman's expertise for a condition
ConditionClose
  • Elite
  • Breast Cancer
    Dr. Feldman is
    Elite
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Intraductal Papilloma
    Dr. Feldman is
    Elite
    . Learn about Intraductal Papilloma.
    See more Intraductal Papilloma experts
  • Mastectomy
    Dr. Feldman is
    Elite
    . Learn about Mastectomy.
    See more Mastectomy experts
  • Distinguished
  • Angiosarcoma
    Dr. Feldman is
    Distinguished
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Inflammatory Breast Cancer
    Dr. Feldman is
    Distinguished
    . Learn about Inflammatory Breast Cancer.
    See more Inflammatory Breast Cancer experts
  • Lymphedema
    Dr. Feldman is
    Distinguished
    . Learn about Lymphedema.
    See more Lymphedema experts
  • Paget Disease of the Breast
    Dr. Feldman is
    Distinguished
    . Learn about Paget Disease of the Breast.
    See more Paget Disease of the Breast experts
  • Advanced
  • Lymphadenectomy
    Dr. Feldman is
    Advanced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Milroy Disease
    Dr. Feldman is
    Advanced
    . Learn about Milroy Disease.
    See more Milroy Disease experts
  • Ptosis
    Dr. Feldman is
    Advanced
    . Learn about Ptosis.
    See more Ptosis experts
  • Experienced
  • Breast Cancer in Men
    Dr. Feldman is
    Experienced
    . Learn about Breast Cancer in Men.
    See more Breast Cancer in Men experts
  • Breast Enlargement In Males
    Dr. Feldman is
    Experienced
    . Learn about Breast Enlargement In Males.
    See more Breast Enlargement In Males experts
  • Breast Infection
    Dr. Feldman is
    Experienced
    . Learn about Breast Infection.
    See more Breast Infection experts
  • Breast Lump
    Dr. Feldman is
    Experienced
    . Learn about Breast Lump.
    See more Breast Lump experts
  • Fibroadenoma
    Dr. Feldman is
    Experienced
    . Learn about Fibroadenoma.
    See more Fibroadenoma experts
  • Fibrocystic Breast Disease
    Dr. Feldman is
    Experienced
    . Learn about Fibrocystic Breast Disease.
    See more Fibrocystic Breast Disease experts
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. General Surgeons Bronx, NY
  3. Dr. Sheldon M. Feldman
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.